|Title:||Intercountry consultaiton on elimination of kala-azar in the South-East Asia Region : Kolkata, India, 9-10 November 2011|
|Authors:||World Health Organization, Regional Office for South-East Asia|
|Publisher:||WHO Regional Office for South-East Asia|
|Place of publication:||New Delhi|
|Abstract:||Kala-azar is endemic in 109 districts in Bangladesh, India and Nepal. There has been a shift of kala-azar patients, who were going to private practitioners. Nongovernmental organizations are now seeking treatment for kala-azar patients from the public sector due to its better public health facilities and provision of incentives to kala-azar patients. The kala-azar endemic areas are contiguous, and large populations live in border areas. These populations are vulnerable to vector-borne diseases owing to poverty, mass movement of population, difficult access to health care and weak cross-border collaboration and weak delivery of health services. The Regional Technical Advisory Group for the Kala-azar Elimination Programme has recommended single-dose AmBisome as the first choice, and combination regimens as the second choice for the treatment of kalaazar in the Indian subcontinent.|
|Gov't Doc #:||SEA-CD-241|
|Appears in Collections:||Meeting Reports|
Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.